SOPHiA GENETICS Balance Sheet Health
Financial Health criteria checks 4/6
SOPHiA GENETICS has a total shareholder equity of $113.5M and total debt of $13.2M, which brings its debt-to-equity ratio to 11.6%. Its total assets and total liabilities are $177.6M and $64.1M respectively.
Key information
11.6%
Debt to equity ratio
US$13.16m
Debt
| Interest coverage ratio | n/a |
| Cash | US$95.79m |
| Equity | US$113.51m |
| Total liabilities | US$64.10m |
| Total assets | US$177.61m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 90B's short term assets ($117.2M) exceed its short term liabilities ($30.9M).
Long Term Liabilities: 90B's short term assets ($117.2M) exceed its long term liabilities ($33.2M).
Debt to Equity History and Analysis
Debt Level: 90B has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 90B's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 90B has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 90B has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.